Remote Jobs at Climb Bio

Climb Bio

11 - 50 employees

Founded 2018

🏥 Healthcare

🧬 Biotechnology

💊 Pharmaceuticals

Healthcare • Biotechnology • Pharmaceuticals

Climb Bio is a clinical-stage biotechnology company developing differentiated monoclonal antibody therapies to treat immune-mediated diseases. The company is advancing a pipeline that includes programs such as budoprutug (CLYM116) and is exploring CD19-directed opportunities across indications with high unmet need. Climb Bio focuses on diseases like primary membranous nephropathy, immune thrombocytopenia, systemic lupus erythematosus, and IgA nephropathy, conducting clinical trials and emphasizing patient-centered development.